These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12921328)

  • 1. Cardiac resynchronization in heart failure.
    Sra JS
    Indian Heart J; 2003; 55(2):125-46. PubMed ID: 12921328
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathobiology of left ventricular dyssynchrony and resynchronization.
    Spragg DD; Kass DA
    Prog Cardiovasc Dis; 2006; 49(1):26-41. PubMed ID: 16867848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of conduction time intervals on symptoms and exercise tolerance in patients with heart failure with left ventricular systolic dysfunction.
    Champagne de Labriolle A; Leclercq C; Daubert JC
    Heart; 2005 Sep; 91(9):1211-2. PubMed ID: 16103561
    [No Abstract]   [Full Text] [Related]  

  • 5. Arterial load reduction after cardiac resynchronization therapy: why does it change?
    Zócalo Y; Bia D; Reyes-Caorsi W; González-Moreno J; Armentano RL
    Eur J Echocardiogr; 2009 Jun; 10(4):461-2; author reply 462-3. PubMed ID: 19398475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiac resynchronization therapy in refractory heart failure].
    Lelakowski J; Czunko A; Majewski J; Bednarek J; Małecka B; Dreher A; Kołacz P
    Pol Merkur Lekarski; 2005 Apr; 18(106):440-5. PubMed ID: 16161931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time intervals of cardiac resynchronization therapy in heart failure.
    Baker C; Love CJ; Moeschberger ML; Orsinelli DA; Yamokoski L; Leier CV
    Am J Cardiol; 2004 Nov; 94(9):1192-6. PubMed ID: 15518621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.
    Bennett KM; Hernandez AF; Chen AY; Mulgund J; Newby LK; Rumsfeld JS; Hochman JS; Hoekstra JW; Ohman EM; Gibler WB; Roe MT; Peterson ED
    Am J Cardiol; 2007 May; 99(10):1351-6. PubMed ID: 17493458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular conduction delays and relation to QRS configuration in patients with left ventricular dysfunction.
    Varma N
    Am J Cardiol; 2009 Jun; 103(11):1578-85. PubMed ID: 19463519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QRS widening as a marker of dys-synchrony.
    Bhatia V; Mathew B
    Indian Heart J; 2003; 55(3):281; author reply 282. PubMed ID: 14560944
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications.
    Nagueh SF
    J Am Coll Cardiol; 2008 Jan; 51(1):18-22. PubMed ID: 18174031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular lead placement in cardiac resynchronization therapy: where and how?
    Khan FZ; Virdee MS; Fynn SP; Dutka DP
    Europace; 2009 May; 11(5):554-61. PubMed ID: 19372115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the pathophysiological basics of cardiac resynchronization therapy.
    Auricchio A; Prinzen FW
    Europace; 2008 Jul; 10(7):797-800. PubMed ID: 18482999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization techniques in cardiac resynchronization therapy.
    Fischer A
    Future Cardiol; 2009 Jul; 5(4):355-65. PubMed ID: 19656060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventional electrophysiology and cardiac resynchronization therapy: delivering electrical therapies for heart failure.
    Burkhardt JD; Wilkoff BL
    Circulation; 2007 Apr; 115(16):2208-20. PubMed ID: 17452619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients with preserved and depressed left ventricular function.
    Lesman-Leegte I; Jaarsma T; van Veldhuisen DJ
    Eur Heart J; 2005 Mar; 26(5):525-6; author reply 526. PubMed ID: 15701655
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.